PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.04%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-10.64%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-21.50%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-21.50%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-35.24%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-34.91%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-34.22%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-7.58%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-7.72%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
7.77%
Dividend growth above 1.5x MTDR's 0.08%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
2.36%
Positive OCF growth while MTDR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-43.26%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
141.25%
10Y revenue/share CAGR under 50% of MTDR's 690.14%. Michael Burry would suspect a lasting competitive disadvantage.
294.39%
5Y revenue/share CAGR under 50% of MTDR's 1272.50%. Michael Burry would suspect a significant competitive gap or product weakness.
182.48%
Positive 3Y CAGR while MTDR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
535.10%
5Y OCF/share CAGR 1.25-1.5x MTDR's 362.73%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
159.28%
Positive 3Y OCF/share CAGR while MTDR is negative. John Neff might see a big short-term edge in operational efficiency.
268.40%
Net income/share CAGR above 1.5x MTDR's 163.75% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
833.89%
5Y net income/share CAGR above 1.5x MTDR's 139.65%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
194.88%
Positive short-term CAGR while MTDR is negative. John Neff would see a clear advantage in near-term profit trajectory.
441.52%
10Y equity/share CAGR above 1.5x MTDR's 274.37%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
202.11%
5Y equity/share CAGR is in line with MTDR's 204.54%. Walter Schloss would see parallel mid-term profitability and retention policies.
103.73%
3Y equity/share CAGR similar to MTDR's 101.40%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
355.97%
Dividend/share CAGR of 355.97% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
314.57%
3Y dividend/share CAGR at 50-75% of MTDR's 529.33%. Martin Whitman might see a weaker short-term approach to distributing cash.
-3.46%
Firm’s AR is declining while MTDR shows 2.38%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
12.45%
Inventory growth well above MTDR's 23.07%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.76%
Asset growth above 1.5x MTDR's 1.79%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
16.95%
BV/share growth above 1.5x MTDR's 2.09%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.17%
We’re deleveraging while MTDR stands at 0.54%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-22.95%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.